The new service monitors 37 types of alarms and 26 operating parameters to provide a status overview of the freezers.
Thermo Fisher Scientific’s addition of the Thermo Scientific Smart Connected Services for its wifi-connected Thermo Scientific TSX Series Ultra-Low Temperature (ULT) Freezers enhances the collection and monitoring of performance data in regard to sample and product protection.
The new service, launched in October 2020, monitors 37 types of alarms and 26 operating parameters to provide a status overview of the TSX Series ULT Freezers. The monitors and alarms include ambient and cabinet temperature, power failure, battery status, door ajar, connectivity signal, and filter efficacy.
Additionally, as part of the new service, Thermo Fisher’s technical experts will examine the collected data to pinpoint out-of-specification operation and offer laboratories reactive warnings and long-term maintenance recommendations.
"Maintaining sample safety and integrity is paramount for life science research and clinical laboratories, and ULT freezers are a critical component of that work," said Sue Lambert, senior director of services for Laboratory Products at Thermo Fisher Scientific, in an Oct. 5, 2020 company press release. "However, monitoring the performance of ULT freezers can be costly, lengthy, and resource-intensive. The new Smart Connected Services feature is designed to give our customers peace of mind that their systems are operating properly. This service helps us provide our customers with actionable intelligence in both a reactive and proactive manner to guide well-informed, timely decision-making to actively protect sample and product integrity."
Source: Thermo Fisher Scientific
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.